Patent applications can do is to be expected in the medical technology industry? Recent studies suggest that certain features of the patent applications with an increased risk that some patents tend to correlate to court over. Innovation is the heart of the medical technology industry. Like many other industries, if you are not constantly with new products and technologies on the market, there is a good chance that you will not survive. Successful businesses, and continue to survive for millions of dollars in research and development invest each year to new or improved products create. Successful businesses, and continue to survive for millions of dollars in research and development invest each year to new or improved products create. Not only are these companies investing in the development of new technologies, but also in the protection of their innovations through the patent system to invest. In fact, for the fiscal year 2006, the U.S. Patent and Trademark Office (USPTO) a record of more than 440,000 patent applications filed, more than twice as many submissions reported a decade ago.
Of course, with a record number of patent applications, and the large number of patents per year, it would be logical to expect that the number of complaints relating to patents would also increase. Recent statistics have tended to this logic, that increasingly the courts to protect their valuable IP assets to support patent holders. For example, from 1995 to 2005, the number of patent cases in the United States from about 1700 to about 2700, filed as an increase of 58% in just 10 years.
However, the probability of a study on the basis of probabilities is small. While the number of patent lawsuits filed are grown in the last ten years, it is interesting to note that recent studies estimate that on average only about 1% of U.S. patents are challenged. However, these studies also note a number of characteristics to predict whether a patent will probably tend to be discussed. These characteristics include: (a) the number of requests to describe the invention, (2) the number and types of prior art citations, and (3) The overcrowding “of the technological field. Each feature is described below, including how the function of the medical device industry is concerned.
Number of claims
A patent must be at least a claim that describes exactly what the applicant regards as his invention. The claims of the patent is often compared with the description of the property in a deed of real estate, both for defining the limits and scope of the property. Because the claims define the limits of the invention, the applicant has an interest in the definition of the invention by a number of broad claims. But in some areas of technology where a large amount of the prior art, the applicant may be avoided, the invention by a number of demands, close define valid state of the art.
As the number of claims in a patent correlated with the probability that the patent is one day a dispute? Empirical studies have found that the disputed patents are a greater number of claims as non-patent litigation against it. In fact, in one study finds that the patents in dispute for nearly 20 applications, on average, had not compared with only 13 patents in dispute. The researchers identify a number of reasons that explain their findings to help: the perceived value of the patent and the quantity on the technology protected by patents.
The claims are simply the most important part of the patent. So it is little wonder that applications to develop and track are expensive. Put more money to a greater number of claims suggests that the patentee believes one more claims may be more useful. However, some researchers conclude that the reason for patent disputes have a number of non-patent claims, that the patentee knew Pat would be useful if the possibility of further litigation and more claims, standing for help in disputes.
The technology is protected by patents, may also explain why patents are challenged with a large number of claims sooner. In a crowded field of technology, it is likely that several competitors to develop similar products. It therefore seems logical that patents are a large number of applications in the urban centers tend to conflict with the competitors.
A general idea of how the number of applications relating to the medical device industry, 50 patents issued recently endoscopes have been analyzed. The results show an average of 17 patent applications. This number is disputed somewhere in the middle of the number of patent applications and cited undisputed. It seems likely, based on empirical studies, that these patents will be more discussed. In addition to better the chances processed, could these results point out that the medical-industrial value of its patent disputes and has overcrowded, with the end result of patents with more claims.
Prior Art Citations
Under U.S. patent, the inventor and any other person, the substance in the preparation and prosecution of the application is a duty, all known information about the examination of the patentability of the invention disclosed. To fulfill this requirement, applicants for patents in general file, which as a condition of disclosure, which is commonly known as an IDS. In IDS, the applicant list of all U.S. patents, foreign patents, and the NPL they know and relate to the invention. In addition, a USPTO patent examiner is looking to the state of the art and are prior art against the applicant, not yet revealed previously in a IDS.
When a patent is granted, are the quotations of the art recording during prosecution before the USPTO are listed in the patent. The researchers used the citation information to the conclusion that the number of citations of prior art is contained in a patent is a good indicator of whether a patent is likely to be discussed. A study showed that the disputed patents cited an average of 14.2 U.S. patents, while non-patent disputes cited only 8.6 U.S. patents. The study also showed that the disputed patents are cited rather than state of the art of other patents, and that the disputed patents are more self-citations, ie, citations, patents owned by others by the same assignee.
How to compare the patents of the medical industry? was also with the small sample of patents described endoscope as a proxy for the medical device industry, the average number of U.S. patents cited as 37th It is much more than findings of the study of United States patent 14.2. If the result means that patents for medical devices are more likely to be questioned? Not necessarily. The study notes that there are two categories of prior art citations (citations and quotations-even) more important predictors of litigation. Although the study did not mean for the self-quotation, he finds that the patents in question have received an average of 12.2 citations of other patents, compared to only 4.1 citations received in average for non-patent disputes. were the average number of citations and self-citations received by patents endoscope only 1.74 and 0.34, respectively. However, as the study’s authors recommend that the number of citations of prior art in this reduced set of samples may indicate that the applicant has made it possible litigation and reasonable steps to make is the strongest patents possible. Similarly, the number of citations are by tests, state of the art in the crowded field of medical devices and ultra-competitive work around.
Crowded Fields
The two features discussed previously disputed patents discussed the idea of the technical areas are overcrowded. It may be obvious, but the term “overcrowded area” refers to a technology where many competitors and given a number of patents that define the technology. So, to be spent on the patents in a crowded area, it there is more competition in the definition and therefore more chance that the patent can be challenged.
In the current system of classification of U.S. patents, which includes more than 430 classes, it seems to eight classes, which are directly connected with the medical technology industry. In these eight classes, there are more than 2,300 sub-classes can be classified in which a medical device patent. The large number of classes and subclasses seems to indicate that the area of medical devices, as a whole, would be more likely than urban centers. In addition, most manufacturers of medical complex and have a better understanding of the value of their intellectual property. Innovation is the cornerstone of the industry, it is logical that the industry is more from their inventions, which protects led to several patents issued medical device. For example, in order to reach several patents in the technology a greater likelihood of patent litigation in this area.
At least one study shows that patents on medical devices are much more likely than the average of all patents are challenged. The study provides an explanation of why patents for medical devices rather by the finding that the medical device industry will be challenged as a whole, patents as valuable assets.
